TG Therapeutics Inc banner

TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 29.99 USD -4.82%
Market Cap: $4.8B

Wall Street
Price Targets

TGTX Price Targets Summary
TG Therapeutics Inc

Wall Street analysts forecast TGTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TGTX is 45.05 USD with a low forecast of 15.15 USD and a high forecast of 63 USD.

Lowest
Price Target
15.15 USD
49% Downside
Average
Price Target
45.05 USD
50% Upside
Highest
Price Target
63 USD
110% Upside
TG Therapeutics Inc Competitors:
Price Targets
NSIT
Insight Enterprises Inc
68% Upside
INO
Inovio Pharmaceuticals Inc
398% Upside
AKTIA
Aktia Bank Abp
1% Upside
EOLS
Evolus Inc
210% Upside

Revenue
Forecast

N/A
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate of TG Therapeutics Inc's revenue for the next 3 years is 35%.

Operating Income
Forecast

N/A
Past Growth
73% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
73% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 73%.

Net Income
Forecast

N/A
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss
N/A
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 3%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TGTX's stock price target?
Price Target
45.05 USD

According to Wall Street analysts, the average 1-year price target for TGTX is 45.05 USD with a low forecast of 15.15 USD and a high forecast of 63 USD.

What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
35%

The compound annual growth rate of TG Therapeutics Inc's revenue for the next 3 years is 35%.

What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
73%

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 73%.

What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
3%

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett